For the Inventor, By the Inventor

Enter assignee name

Laboratoires Serono S.a.

USPTO Granted Patents = 40

EPO Patents = 2

Forward Citations = 72

Loading Chart...

Loading Chart...

90 inventors (with patents filed for the assignee):

Jean-Pierre Gotteland (6 out of 20 patents)

Dennis Church (5 out of 18 patents)

Amanda Proudfoot (5 out of 13 patents)

4. Matthias Schwarz (4 out of 35 patents)

5. Agnes Bombrun (4 out of 24 patents)

6. Yihua Liao (4 out of 8 patents)

7. Serge Halazy (4 out of 14 patents)

8. Thomas Rueckle (4 out of 21 patents)

9. Marco Antonio Biamonte (4 out of 14 patents)

10. Gian Luca Araldi (4 out of 28 patents)

11. Stephen Arkinstall (4 out of 12 patents)

12. Marie Kosco-Vilbois (3 out of 30 patents)

13. Zhong Zhao (3 out of 11 patents)

14. Christine Power (3 out of 23 patents)

15. Dominique Swinnen (3 out of 24 patents)

40 patents: Sort by Forward Citations

1. 7786121 - Derivatives of hydroxamic acid as metalloproteinase inhibitors (2010-08-31),

2. 7696231 - Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) (2010-04-13),

3. 7683078 - Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK's) inhibitors (2010-03-23),

4. 7638538 - Pharmaceutically active sulfonyl amino acid derivatives (2009-12-29),

5. 7638480 - Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease (2009-12-29),

6. 7635713 - Pyrrolidine derivatives as prostaglandin modulators (2009-12-22),

7. 7592477 - Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) (2009-09-22),

8. 7557136 - Pyrrolidine derivatives as oxytocin antagonists (2009-07-07),

9. 7550563 - Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain (2009-06-23),

10. 7544700 - Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases (2009-06-09),

11. 7541375 - Azole derivatives and pharmaceutical compositions containing them (2009-06-02),

12. 7507707 - Methods of inducing ovulation using a non-polypeptide camp level modulator (2009-03-24),

13. 7479575 - Method for preparing para-phenyl alkynyl benzaldehydes (2009-01-20),

14. 7479486 - Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids (2009-01-20),

15. 7476381 - Methods of reducing serum alanine transferase levels in a subject with hepatitis (2009-01-13),

Laboratoires Serono S.A. is a pharmaceutical company specializing in biotechnology. They develop and manufacture innovative prescription drugs for various therapeutic areas, including reproductive health, neurology, and growth hormone deficiencies. With a commitment to improving patients' lives, Laboratoires Serono S.A. focuses on research and development to deliver high-quality and effective medications. Visit their website to learn more about their products and mission.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

40 Patents

#17 in

#329 in Switzerland

#16,532 in the World

Laboratoires Serono S.a.

Forward Citations = 72

90 inventors:

Jean-Pierre Gotteland (6 out of 20 patents)

Dennis Church (5 out of 18 patents)

Amanda Proudfoot (5 out of 13 patents)

4. Matthias Schwarz (4 out of 35 patents)

5. Agnes Bombrun (4 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…